RET and medullary thyroid gland carcinoma: In the other 75% of cases, MTC is a sporadic tumor, and with exception of RAS alterations that have been found in approximately 10% of cases [4, 5], somatic mutations in the RET proto-oncogene appear to be the most common genetic alteration in MTC tumorigenesis [3].